Format

Send to

Choose Destination
See comment in PubMed Commons below
Endocr Regul. 2006 Jun;40(2):53-67.

Thyroglobulin: current status in differentiated thyroid carcinoma (review).

Author information

1
Department of Surgical Oncology, MS Ramaiah Medical College & Hospital, Bangalore, India. drkhari@yahoo.com

Abstract

Thyroglobulin (Tg) measurements in tissue and serum play an important role in the management of differentiated thyroid cancers. In the post thyroid ablation scenario, Tg estimation plays a very important role for detection of recurrence and metastasis. Although there could be Tg autoantibody interference in some patients, Tg is a highly specific and sensitive tumor marker for differentiated thyroid cancer in those where the autoantibody is absent. The clinical sensitivity of Tg is greatest when endogenous TSH is elevated before radioiodine imaging. Tg assays and radioiodine scans are independent indicators of residual or metastatic thyroid cancer, indicating that both these tests are complimentary. Immunohistochemical detection of Tg in surgical specimens is useful in the differential diagnosis of tumors of unknown origin. In future, measurement of Tg mRNA to detect circulating tumor cells may help to overcome some of the current limitations. Key words: Thyroglobulin Serum estimation -Antibodies mRNA testing - Differentiated thyroid cancer Radioiodine Thyroxine TSH Diagnostic use.

PMID:
17100547
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for AEPress, s r. o.
    Loading ...
    Support Center